ORGS

Orgenesis Inc.

Price

$0.35

return (12m)

-65.01%

p/e

-0.04

p/bv

-0.05

DIVIDEND YIELD

0.00%

ORGS price

Orgenesis

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ORGS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

1,649.50%

3 months

3,399.00%

1 year

-65.01%

2 years

-96.24%

5 years

-99.30%

10 years

-99.23%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ORGS

Valuation

P/E

-0.04

Sector -66.00

Industry -66.00

P/BV

-0.05

Sector -3.00

Industry -3.00

P/Revenue (PSR)

1.68

Sector -7.80

Industry -7.80

EV/EBITDA

-0.54

Sector -40,748,258.36

Industry -40,748,258.36

EV/EBIT

-0.53

Sector -43,475,809.65

Industry -43,475,809.65

P/EBITDA

-0.04

Sector -1,341.27

Industry -1,341.27

P/EBIT

-0.04

Sector -448.79

Industry -448.79

P/Total Assets

1.30

Sector 1.05

Industry 1.05

P/Net Current Assets

-0.05

Sector -12,585,111.43

Industry -12,585,111.43

P/Working Capital

-0.07

Sector -3,247,398.66

Industry -3,247,398.66

EPS

-9.63

Sector -12,227.97

Industry -12,227.97

BVPS

-7.51

Sector -5,764.06

Industry -5,764.06

Efficiency

Gross Margin

-100.00%

Sector 23.92%

Industry 23.92%

EBITDA Margin

-6,203.33%

Sector -16,313.59%

Industry -16,313.59%

EBIT Margin

-6,356.67%

Sector -4,256,416.89%

Industry -4,256,416.89%

Operating Margin

-100.00%

Sector -53.16%

Industry -53.16%

Net Profit Margins

-100.00%

Sector -54.70%

Industry -54.70%

Asset Turnover

0.22

Sector 0.03

Industry 0.03

Profitability

ROE

128.35%

Sector -3,314.88%

Industry -3,314.88%

ROA

-3,568.15%

Sector -295.98%

Industry -295.98%

ROIC

-123.35%

Sector -2,109.21%

Industry -2,109.21%

Dividends

Dividend yield

0.00%

Sector -1.03%

Industry -1.03%

Payout

Sector -

Industry -

Debt

Current Ratio

0.03

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-0.45

Sector -6.09

Industry -6.09

Net Debt / EBIT

-0.44

Sector -3.13

Industry -3.13

Net Debt / Equity

-0.22

Sector -1.08

Industry -1.08

Gross Debt / Equity

-0.23

Sector 0.00

Industry 0.00

Equity/Assets

-27.80

Sector -0.25

Industry -0.25

Liabilities/Assets

28.80

Sector 0.13

Industry 0.13

Growth

5Y Revenue CAGR

510.07%

Sector -

Industry -

5Y Earnings CAGR

1,523.67%

Sector -

Industry -

Fundamentals ORGS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ORGS Orgenesis Inc.	$0.35	-60.69%	0.00%	-0.04	-0.05	128.35%	-100.00%
JNJ Johnson & Johnson	$260.56	53.94%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$26.78	15.88%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$249.75	29.02%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.08	-4.01%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$134.41	69.01%	2.52%	103.94	7.86	7.56%	4.77%
AZN AstraZeneca PLC	$155.78	1.68%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$63.93	39.94%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$74.44	-50.06%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$802.27	42.53%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$412.19	47.64%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$98.35	51.01%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$866.22	31.29%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$507.39	28.15%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$233.04	59.34%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$38.08	3.85%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$208.88	54.51%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ORGS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Orgenesis

Orgenesis Inc.

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

2010

Time since IPO - 16 years

309

Employees

Orgenesis Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.75 million, with shareholders equity totaling $-37.53 million.

The company employs approximately 309 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Orgenesis Inc. reported $1.04 million in revenue, generating net income of $-48.17 million.

Key financial metrics include a P/E ratio of -0.04, a price-to-book (P/B) ratio of -0.05, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ORGS.

Market cap

$1.75 million

Net worth

$-37.53 million

$-37,530,000.00

Assets

$1.35 million

$1,350,000.00

Total Shares Outstanding

5.00 million

5,000,000

Average Daily Trading Volume

$240.42

Sector

Health Care

Industry

Biotechnology

ORGS

ORGS revenue and profits

Financial Results ORGS

DRAG THE FRAME TO SEE MORE DATA

ORGS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$866.22 29,22% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$233.04 57,40% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$260.56 51,21% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$249.75 24,69% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$134.41 64,90% (12M)

P/E

103.94

2.52%

ROE

7.56%

P/BV

7.86

AZN - AstraZeneca

$155.78 0,17% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$26.78 13,98% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$866.22 29,22% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$233.04 57,40% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$260.56 51,21% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$249.75 24,69% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$134.41 64,90% (12 M)

P/L

103.94

2.52%

ROE

7.56%

P/VP

7.86

AZN - AstraZeneca

$155.78 0,17% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$26.78 13,98% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Orgenesis (ORGS) today?

A cotação de Orgenesis (ORGS) hoje está em US$ 0.35, com uma variação de -65.01% em relação ao último ano. A cotação de Orgenesis (ORGS) iniciou o ano negociando na casa dos US$ 0.15 e hoje está em US$ 0.35. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Orgenesis (ORGS) e dados de ações do Ibovespa e mercados internacionais.

Quando Orgenesis (ORGS) paga dividendos?

Orgenesis (ORGS) não distribuiu dividendos no último ano.

Is Orgenesis (ORGS) a good investment?

Atualmente, Orgenesis (ORGS) está cotada a US$ 0.35, com um P/L de -0.04, representando um desvio de -141% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -65.01 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -65.01%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Orgenesis (ORGS) stock?

Investir em ações de Orgenesis (ORGS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Orgenesis (ORGS) yield today?

A rentabilidade de Orgenesis (ORGS) foi de 1,649.50% no último mês, -65.01% no último ano e -99.30% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Orgenesis (ORGS) hoje, o investimento total seria de US$ 34.99, com base na cotação atual de US$ 0.35.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 12.24
Em 5 anos: US$ 0.24
Em 10 anos: US$ 0.27

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ORGS

Orgenesis Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ORGS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ORGS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Orgenesis

Orgenesis Inc.

United States

18 years

2010

309

PROFIT X PRICE ORGS

Financial Results ORGS

ORGS cash flow

Asset, Revenue and Profit Growth - ORGS

ORGS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions